SE464616B - Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen - Google Patents

Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen

Info

Publication number
SE464616B
SE464616B SE7801268A SE7801268A SE464616B SE 464616 B SE464616 B SE 464616B SE 7801268 A SE7801268 A SE 7801268A SE 7801268 A SE7801268 A SE 7801268A SE 464616 B SE464616 B SE 464616B
Authority
SE
Sweden
Prior art keywords
copolymes
lysin
conjugated
procedure
cell
Prior art date
Application number
SE7801268A
Other languages
English (en)
Swedish (sv)
Other versions
SE7801268L (sv
Inventor
D H Katz
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of SE7801268L publication Critical patent/SE7801268L/xx
Publication of SE464616B publication Critical patent/SE464616B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7801268A 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen SE464616B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (2)

Publication Number Publication Date
SE7801268L SE7801268L (sv) 1978-08-04
SE464616B true SE464616B (sv) 1991-05-27

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801268A SE464616B (sv) 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen

Country Status (17)

Country Link
US (1) US4191668A (de)
JP (1) JPS53121943A (de)
AU (1) AU515181B2 (de)
BE (1) BE863656A (de)
CA (1) CA1118347A (de)
CH (1) CH644521A5 (de)
DE (1) DE2804457C2 (de)
DK (1) DK155174C (de)
FI (1) FI780312A7 (de)
FR (1) FR2379287A1 (de)
GB (1) GB1599454A (de)
LU (1) LU78997A1 (de)
MX (1) MX6266E (de)
NL (1) NL7801220A (de)
NO (1) NO153419C (de)
SE (1) SE464616B (de)
ZA (1) ZA78613B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (de) * 1981-10-09 1983-04-20 Beecham Group Plc Veränderte Allergenen
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US6022544A (en) * 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
IE922292A1 (en) * 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6458953B1 (en) 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US20030039659A1 (en) * 1999-09-24 2003-02-27 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
CN1434726A (zh) 2000-06-08 2003-08-06 拉卓拉药物公司 包含高分子量聚环氧乙烷的多价平台分子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation

Also Published As

Publication number Publication date
JPH0428689B2 (de) 1992-05-15
DK155174B (da) 1989-02-27
DK49178A (da) 1978-08-04
MX6266E (es) 1985-02-27
NO780366L (no) 1978-08-04
DK155174C (da) 1989-07-10
AU3293378A (en) 1979-08-09
CA1118347A (en) 1982-02-16
ZA78613B (en) 1978-12-27
NL7801220A (nl) 1978-08-07
FR2379287B1 (de) 1980-08-29
LU78997A1 (fr) 1978-06-21
FR2379287A1 (fr) 1978-09-01
US4191668A (en) 1980-03-04
AU515181B2 (en) 1981-03-19
BE863656A (fr) 1978-05-29
DE2804457C2 (de) 1984-04-12
NO153419B (no) 1985-12-09
CH644521A5 (de) 1984-08-15
JPS53121943A (en) 1978-10-24
DE2804457A1 (de) 1978-08-10
FI780312A7 (fi) 1978-08-04
NO153419C (no) 1986-03-19
SE7801268L (sv) 1978-08-04
GB1599454A (en) 1981-10-07

Similar Documents

Publication Publication Date Title
SE464616B (sv) Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen
FI800182A7 (fi) Testmedel och foerfarande foer stoerningsfri bestaemning av oxiderade medel
SE432432B (sv) Forfarande och medel for fornetning av halogenhaltiga polymerer
SE7804376L (sv) Forfarande och medel for tryckning
SE7800021L (sv) Medel for forbettring av genomblodning och sarlekning
FI802190A7 (fi) Vinylpolymer med acetylacetoxigrupper foerfarande foer dess framstaellning och medel innehaollande det
FI783638A7 (fi) Fenylglycinderivat och speciellt substituerade amidderivat av l- och dl-fenylglycin
SE7713322L (sv) Insekticidala och akaricidala medel
SE7810393L (sv) Insekticida och akaricida medel
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
FI802430A7 (fi) Foerfarande foer belaeggning av formmassor av finfoerdelade expanderbara styrenpolymerisat med dispersioner av i och foer sig kaenda belaeggningsmedel och anvaendning av formmassorna foer framstaellning av skumplastformkroppar
DK144657C (da) Fremgangsmaade til fremstilling af antibiotikum c-15003 p-3
FI780288A7 (fi) Foerfarande och anordning foer utslaetning och riktning av band
SE431292B (sv) Forfarande och anordning for sprayning
BE864584A (fr) Composes azoiques et leur preparation
FI783064A7 (fi) Vals foer tryckbehandling av varubanor och foerfarande foer deras framstaellning
FI783185A7 (fi) Foerbaettringar i och angaoende uppmjukningsmedel foer tyg
FI783129A7 (fi) Saett och anordning foer sterilisering med formalin
SE7802024L (sv) Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner
FI782241A7 (fi) Foerfarande foer framstaellning av p-hydroxifenylglycin och n-alkyl- och n n-dialkylderivat daerav
FI781399A7 (fi) Rao- och fyllmassa foer livs- och njutningsmedel och foerfarande foer dess framstaellning
SE7812832L (sv) 2'-n-acyl och alkyl-6'-n-alkyl- och 6',6'-di-n-alkyl-derivat av fortimiciner a och b
FI783019A7 (fi) Foerfarande foer foerbaettring av arom smak och faerg av konserverade musselprodukter
SE7802655L (sv) Medel for bekempning av koccididioser och helmintiaser
FI772858A7 (fi) Avmagningsmedel och foerfarande foer framstaellning daerav